N. Petrovsky

发表

Eye Movements as Biomarkers to Evaluate Pharmacological Effects on Brain Systems

U. Ettinger, J. Reilly, Tatiana M. Karpouzian, 2019, Eye Movement Research.

Sensorimotor Gating Depends on Polymorphisms of the Serotonin-2A Receptor and Catechol-O-Methyltransferase, but Not on Neuregulin-1 Arg38Gln Genotype: A Replication Study

Michael Wagner, Ulrich Ettinger, David A. Collier, 2009, Biological Psychiatry.

Functional Polymorphism in the Neuropeptide Y Gene Promoter (rs16147) Is Associated with Serum Leptin Levels and Waist-Hip Ratio in Women

T. Wienker, G. Winterer, Elvira Abbruzzese, 2013, Annals of Nutrition and Metabolism.

Replication of the association between CHRNA4 rs1044396 and harm avoidance in a large population-based sample

T. Wienker, G. Winterer, J. Kornhuber, 2016, European Neuropsychopharmacology.

Nicotine differentially modulates antisaccade performance in healthy male non-smokers stratified for low and high accuracy

W. Maier, U. Ettinger, H. Kessler, 2011 .

Sleep deprivation as an experimental model system for psychosis: Effects on smooth pursuit, prosaccades, and antisaccades

Ulrich Ettinger, Veena Kumari, Inga Meyhöfer, 2017, Journal of Psychopharmacology.

CHRFAM7A copy number and 2-bp deletion polymorphisms and antisaccade performance.

D. Collier, V. Kumari, U. Ettinger, 2009, The international journal of neuropsychopharmacology.

The effects of positive schizotypy and sleep deprivation on prepulse inhibition

V. Kumari, U. Ettinger, I. Meyhöfer, 2019, Schizophrenia Research.

Sensorimotor Gating is Associated with CHRNA3 Polymorphisms in Schizophrenia and Healthy Volunteers

Michael Wagner, Ulrich Ettinger, Veena Kumari, 2010, Neuropsychopharmacology.

Sleep Deprivation Disrupts Prepulse Inhibition and Induces Psychosis-Like Symptoms in Healthy Humans

V. Kumari, U. Ettinger, M. Wagner, 2014, The Journal of Neuroscience.

Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating

Jürgen Gallinat, Peter Nürnberg, Norbert Dahmen, 2012, Proceedings of the National Academy of Sciences.

Effects of nicotine and atomoxetine on brain function during response inhibition

U. Ettinger, P. Trautner, A. Kasparbauer, 2019, European Neuropsychopharmacology.

Nicotine differentially modulates antisaccade performance in healthy male non-smoking volunteers stratified for low and high accuracy

Michael Wagner, Henrik Walter, Henrik Kessler, 2012, Psychopharmacology.

Sustained incentive value of heroin-related cues in short- and long-term abstinent heroin users

A. Rehme, B. Quednow, K. Preller, 2013, European Neuropsychopharmacology.

The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal memory and the acoustic startle response.

W. Maier, W. Gaebel, W. Wölwer, 2012, The international journal of neuropsychopharmacology.

Antisaccade performance is related to genetic loading for schizophrenia.

W. Maier, U. Ettinger, M. Wagner, 2009, Journal of psychiatric research.

Neurocognitive impairments in non‐deprived smokers—results from a population‐based multi‐center study on smoking‐related behavior

T. Wienker, G. Winterer, J. Gallinat, 2013, Addiction biology.

N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia.

Michael Wagner, Alois M Sprinkart, Wolfgang Block, 2013, Schizophrenia bulletin.

Nicotine enhances antisaccade performance in schizophrenia patients and healthy controls.

W. Maier, U. Ettinger, N. Dahmen, 2013, The international journal of neuropsychopharmacology.

Motivational Modulation of the Attentional Blink

N. Petrovsky, 2006 .

The effect of nicotine on sensorimotor gating is modulated by a CHRNA3 polymorphism

W. Maier, U. Ettinger, N. Dahmen, 2013, Psychopharmacology.

Genetic Variation in the Neuropeptide Y Gene Promoter Is Associated with Increased Risk of Tobacco Smoking

T. Wienker, J. Brinkmeyer, G. Winterer, 2012, European Addiction Research.

Effects of nicotine on response inhibition and interference control

R. Chan, V. Kumari, U. Ettinger, 2017, Psychopharmacology.

Neurocognitive functioning in parents of schizophrenia patients: Attentional and executive performance vary with genetic loading

W. Maier, U. Ettinger, M. Wagner, 2015, Psychiatry Research.

Lack of association of a functional catechol-O-methyltransferase gene polymorphism with risk of tobacco smoking: results from a multicenter case-control study.

T. Wienker, G. Winterer, Elvira Abbruzzese, 2013, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Sensorimotor Gating is Associated with CHRNA3 Polymorphisms in Schizophrenia and Healthy Volunteers

D. Collier, W. Maier, V. Kumari, 2010, Neuropsychopharmacology.

The Attentional Blink

N. Petrovsky, 2008 .

N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia.

F. Jessen, W. Maier, H. Schild, 2013, Schizophrenia bulletin.

Nicotine differentially modulates antisaccade performance in healthy male non-smoking volunteers stratified for low and high accuracy

W. Maier, K. Schnell, H. Walter, 2011, Psychopharmacology.

Replication of the association between CHRNA4 rs1044396 and harm avoidance in a large population-based sample

T. Wienker, G. Winterer, J. Kornhuber, 2016, European Neuropsychopharmacology.